Howard Feldman
Works at
University of California, San Diego
Professor of neurosceinces
Sources: reporter.nih.gov
Grants and prizes
R01, Phase II randomized controlled trial of benfotiamine in early Alzheimer's Disease, R01AG076634, 2022–2028, 26 Aug 2026
R01, A Seamless Phase 2A-B Randomized Double Blind Placebo Controlled Trial to Evaluate the Efficacy and Safety of PQ 912 in Patients with Early Alzheimer's Disease, R01AG061146, 2019–2025, 3 Feb 2023
Sources: reporter.nih.gov